Based on these findings, we hypothesize that sPD-L1 from breast cancer cells actively promotes the differentiation of B cells into Bregs and suppresses antitumor activity both the local TME and the circulation of IBCa patients. The gene discussed is SPDL1; the disease is breast carcinoma.